What Are the Regulatory and Ethical Considerations?
Regulatory bodies like the FDA and EMA have established rigorous guidelines to ensure the safety and efficacy of allogeneic cell therapies. Ethical considerations include informed consent, donor anonymity, and equitable access to treatments. As these therapies often involve genetic modifications, there are additional concerns related to long-term effects and genetic integrity.
